Evidence map›Paper›PMID 35877245›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy.

Seiji Mabuchi, Naoko Komura, Michiko Kodama, Michihide Maeda, Yuri Matsumoto, Shoji Kamiura

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Seiji MabuchiDepartment of Gynecology, Osaka International Cancer Institute, 3-1-69, Otemae, Osaka 541-8567, Japan.
Naoko KomuraDepartment of Obstetrics and Gynecology, Kaizuka City Hospital, Kaizuka 597-0015, Japan.
Michiko KodamaDepartment of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.ORCID 0000-0003-4046-7572
Michihide MaedaDepartment of Gynecology, Osaka International Cancer Institute, 3-1-69, Otemae, Osaka 541-8567, Japan.
Yuri MatsumotoDepartment of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Shoji KamiuraDepartment of Gynecology, Osaka International Cancer Institute, 3-1-69, Otemae, Osaka 541-8567, Japan.ORCID 0000-0002-5723-8891
Osaka International Cancer Institute · JPSuita Tokushukai Hospital · JPTakarazuka City Hospital · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We retrospectively investigated the significance of metastatic lymph nodes in patients with locally recurrent or persistent cervical cancer in a previously irradiated field and subsequently had salvage hysterectomy. Clinical data were obtained from a chart review, and the prognostic impact of the presence, number (1-2 versus ≥3), and location (pelvic versus pelvic plus para-aortic) of lymph node metastasis was investigated by comparing recurrence and survival. In total, 50 patients were included in this study, of which 21 (42.0%) showed pathological evidence of lymph node metastasis (node-positive group). Both the univariate and multivariate analyses showed that lymph node metastasis was an independent prognostic factor for postoperative recurrence (hazard ratio (HR) 5.36; 95% CI 1.41-6.66;

Indexed as

Lymph NodesNeoplasm Recurrence, LocalUterine Cervical NeoplasmsFemaleHumansHysterectomyLymphatic MetastasisLymph Node ExcisionRetrospective StudiesSalvage Therapylymphadenectomylymph node metastasisrecurrent cervical cancersalvage hysterectomysurvival

Identifiers

PMID35877245
PMCPMC9315867
OpenAlexW4285035759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.